BMPR2 and pulmonary arterial hypertension: Using a combination of functional assays, RNA sequencing and pathway analysis in human pulmonary endothelial and smooth muscle cells and cells from PAH patients with disabling BMPR2 mutations under the two-hit conditions, we have identified a microfluidic signature of vascular responses characteristic of PAH.